)
)
Double Bond Pharmaceutical Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Double Bond Pharmaceutical
Access all reports
Double Bond Pharmaceutical International AB is a Sweden-based pharmaceutical company specializing in the development of innovative therapies for cancer and infectious diseases. The company focuses on utilizing advanced drug delivery technologies to improve the efficacy and safety of treatments. Double Bond Pharmaceutical’s research and development efforts aim to address unmet medical needs and provide targeted solutions for patients. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
DBP
Country
🇸🇪 Sweden